A Phase Ib/II Trial of Doxorubicin with Ganetespib, a Novel Hsp90 Inhibitor, in Advanced Solid Tumors, with Dose Expansion in Small Cell Lung Cancer
JOURNAL OF THORACIC ONCOLOGY(2015)
关键词
small cell lung cancer,Hsp-90 inhibitor,ganetespib,chemoresistance
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要